Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=36

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01000727-60160a8d",
        "title": "Darapladib 160 mg vs Placebo: Number of Participants With First Occurrence of Any Coronary Revascularization Procedures (Excluding Coronary Revascularization Planned Prior to Randomization, But Performed After Randomization) During the Time Period for Follow-up of Cardiovascular Event",
        "summary": "926 of 6504 against 967 of 6522; risk difference -0.6 points, 95% interval -1.8 to 0.6; NCT01000727, The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial",
        "record": "/library/comparisons/NCT01000727-60160a8d",
        "nct_id": "NCT01000727",
        "kind": "outcome",
        "participants": 13026,
        "risk_difference": {
          "value": -0.005893478897990467,
          "lower": -0.01800024755142994,
          "upper": 0.006214456656616189
        },
        "group_1": "926 of 6,504",
        "group_2": "967 of 6,522",
        "difference": "-0.6 points",
        "interval": "-1.8 to 0.6",
        "trial_title": "The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial"
      },
      {
        "id": "NCT01000727-6f4c0537",
        "title": "Darapladib 160 mg vs Placebo: Number of Participants With Cardiovascular Death During the Time Period for Follow-up of Cardiovascular Events",
        "summary": "268 of 6522 against 243 of 6504; risk difference 0.4 points, 95% interval -0.3 to 1.0; NCT01000727, The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial",
        "record": "/library/comparisons/NCT01000727-6f4c0537",
        "nct_id": "NCT01000727",
        "kind": "outcome",
        "participants": 13026,
        "risk_difference": {
          "value": 0.0037300660495105387,
          "lower": -0.002950852111549564,
          "upper": 0.010423717236930391
        },
        "group_1": "268 of 6,522",
        "group_2": "243 of 6,504",
        "difference": "0.4 points",
        "interval": "-0.3 to 1.0",
        "trial_title": "The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=37",
  "request_id": "uKfKIFdL6b04w73y"
}